Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Brain Neoplasms 41Carcinoma, Non-Small-Cell Lung 35Neoplasm Metastasis 32Pancreatic Neoplasms 30Prostatic Neoplasms 24Lung Neoplasms 21Carcinoma, Hepatocellular 21Melanoma 16Breast Neoplasms 12Liver Neoplasms 10Glioblastoma 10Squamous Cell Carcinoma of Head and Neck 8Carcinoma, Renal Cell 8Neoplasms 7Head and Neck Neoplasms 7Kidney Neoplasms 6Gliosarcoma 6Sarcoma 5Glioma 5Central Nervous System Neoplasms 5Uterine Cervical Neoplasms 4Salivary Gland Neoplasms 4Colorectal Neoplasms 4Vulvar Neoplasms 3Vaginal Neoplasms 3Recurrence 3Radiation Injuries 3Pain 3Ovarian Neoplasms 3Fallopian Tube Neoplasms 3

Interventions

Cisplatin 30Pemetrexed 21Gemcitabine 11Radiotherapy 6Nivolumab 6Drug Therapy 6Cyclophosphamide 6Carboplatin 6durvalumab 4Vinorelbine 4Chemotherapy, Adjuvant 4tumor necrosis factor-alpha, CNGRC fusion protein, human 3sodium thiosulfate 3sargramostim 3Ipilimumab 3Doxorubicin 3raltitrexed 2pembrolizumab 2cediranib 2SS1(dsFv)PE38 2Radiotherapy, Intensity-Modulated 2Psychiatric Rehabilitation 2Photochemotherapy 2Neoadjuvant Therapy 2Methotrexate 2Interferon-alpha 2Imatinib Mesylate 2Granulocyte-Macrophage Colony-Stimulating Factor 2Gefitinib 2Everolimus 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Mesothelioma, Malignant × Radiosurgery × Clear all
NCT03399552 2023-10-23

Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma

Memorial Sloan Kettering Cancer Center

Phase 1/2 Completed
15 enrolled 8 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡